Loading
Loading…
New: tenders and results on WhatsApp
New: Find tenders, results and companies on WhatsApp, by text or voice note
New: tenders and results on WhatsApp
New: Find tenders, results and companies on WhatsApp, by text or voice note
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | FAIRDEAL HEALTH CARE PRIVATE LIMITEDLikely | Evaluation in Progress | 4 | ₹475 |
| 2 | Schedule 2 | MADHAV PHARMALikely | Evaluation in Progress | 3 | ₹1,550 |
| 3 | Schedule 3 | GURUDEV AGENCIESLikely | Evaluation in Progress | 5 | ₹120 |
| 4 | Schedule 4 | GURUDEV AGENCIESLikely | Evaluation in Progress | 5 | ₹120 |
| 5 | Schedule 5 | GURUDEV AGENCIESLikely | Evaluation in Progress | 5 | ₹720 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
26 Oct 2026, 1:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Published by the portal on this tender, for queries and grievance redressal.
MHC DGLP CELL MARKET SURVEY 04
10039817
GEM/2026/B/8164986
Two Packet Bid
INJ HUMAN MIXTARD 50 50 pfs
Chennai, Tamil Nadu
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
10%
Exempted
Yes
26 Oct 2026
15 Oct 2026
27 Oct 2026
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | INJ HUMAN MIXTARD 50 50 pfs | INJ HUMAN MIXTARD 50-50 pfs | 1 | PFS | Chennai | 30 |
| 2 | Insulin detemir 100IU Inj | Insulin detemir (100IU) Inj | 1 | PFS | Chennai | 30 |
| 3 | INSULIN HIGHLY PURIFIED ISOPHANE HUMAN NPH 40IUML 10 ML INJ | INSULIN HIGHLY PURIFIED ISOPHANE (HUMAN NPH) 40IU/ML, 10 ML INJ | 1 | Vial | Chennai | 30 |
| 4 | INSULIN BIPHASIC ISOPHANE 30PER SOLUBLE INSULIN AND 70PER ISOPHANE INSULIN HUMAN MIXTARD 30 70 INJ | INSULIN BIPHASIC ISOPHANE (30% SOLUBLE INSULIN AND 70% ISOPHANE INSULIN) (HUMAN MIXTARD 30/70) INJ | 1 | Cart | Chennai | 30 |
| 5 | INSULIN LISPRO BIPHASIC 25 75 25PER INSULIN LISPRO AND 75PER INSULINE LISPRO PROTAMINE SUSPENSION 100IUML3ML HUMALOG MIX 25 3ML CARTRIDGE | INSULIN LISPRO BIPHASIC 25/75 (25% INSULIN LISPRO AND 75% INSULINE LISPRO PROTAMINE SUSPENSION 100IU/ML,3ML ) HUMALOG MIX 25 3ML CARTRIDGE | 1 | cart | Chennai | 30 |
| 6 | INSULIN LISPRO BIPHASIC 50PER 50PER INSULIN LISPRO AND 50PER INSULINE LISPRO PROTAMINE SUSPENSION 100IU ML 3ML CART HUMALOG MIX 50 3ML CART | INSULIN LISPRO BIPHASIC 50% (50% INSULIN LISPRO AND 50% INSULINE LISPRO PROTAMINE SUSPENSION 100IU/ML,3ML CART) HUMALOG MIX 50 3ML CART | 1 | cart | Chennai | 30 |
| 7 | INSULIN PREMIXED BIPHASIC HUMAN 50PER HUMAN NEUTRAL 50 PER HUMAN ISOPHANE INSULIN 10 ML INJ | INSULIN PREMIXED BIPHASIC HUMAN (50% HUMAN NEUTRAL 50% HUMAN ISOPHANE INSULIN) 10 ML INJ | 1 | Vial | Chennai | 30 |
| 8 | Inj Biphasic Isophane Insulin 30 Human Insulin 30 Per as Soluble Insuline Plus 70 Per Isophan Insulin Suspension 100IU 3 ml Mixtard | Inj Biphasic Isophane Insulin 30 (Human Insulin 30% as Soluble Insuline + 70 % Isophan Insulin Suspension 100IU, 3 ml) Mixtard | 1 | PFP | Chennai | 30 |
| 9 | Inj Biphasic Isophane Insulin 50 Human Insulin 50 Per as Soluble Insuline Plus 50 PER Isophan Insulin Suspension 100IUml Mixtard 50 3 ml | Inj Biphasic Isophane Insulin 50 (Human Insulin 50% as Soluble Insuline + 50 % Isophan Insulin Suspension 100IU/ml) Mixtard 50, 3 ml | 1 | PFP | Chennai | 30 |
| 10 | Inj Insulin Humalog Lispro Recombinan DNA Origin 100 IUml 3 ml | Inj Insulin Humalog Lispro (Recombinan DNA Origin) 100 IU/ml, 3 ml | 1 | PFS | Chennai | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_10039817.pdf
GEM_BID • 0.17 MB
market_survey_2026-10-15-12-34-18_9e2a30602be118674d46a1c9d3c7dc9f.pdf
BOQ • 0.04 MB
boq_item_sample_file_2026-10-15-12-34-18_5f68ad99dc3122b2024dc028e8389697.csv
BOQ • 0.00 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .